Noa Therapeutics is a preclinical biotech company, pioneering the development of non-steroidal, multimodal small molecules for the tailored treatment of immune diseases involving barrier dysfunction. Adopting a systems biology approach, Noa is able to modulate the efficacy of their novel therapeutics across three discrete targets to enable comprehensive treatment of complex inflammatory barrier diseases spanning gastrointestinal, cardiovascular, pulmonary, central nervous system, dermatological, and ocular indications; targeting underlaying disease pathology, affording the potential to drive disease modification.

Noa Therapeutics logo



Event details

Date: September 18 - 20, 2023

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


15 in total